Williams, Michael E.
Primary Appointment
Byrd S. Leavell Professor of Medicine: Hematology and Oncology, and the UVA NCI Comprehensive Cancer Center, Medicine: Hematology and Oncology
Education
- Clinical Fellowship, Hematology, University of Virginia
- Clinical Fellowship, Oncology, University of Virginia
- Residency, Internal Medicine, University of Virginia
- BS, Botany, Ohio State University
- SM, Microbiology, Harvard University School of Public Health, Boston, MA
- MD, Medicine, University of Cincinnati College of Medicine, Cincinnati, OH
Contact Information
UVA Div. of Hematology-Oncology
PO Box 800716
Charlottesville, VA 22908
Telephone: 434.924.9637
Fax: 434.243.6086
Email: mew4p@virginia.edu
Research Interests
Dr. Williams’ research interests include clinical trials and translational science for mantle cell lymphoma, other non-Hodgkin lymphomas and CLL, with a focus on targeted agents and immuno-therapeutics. He was a co-investigator on three pivotal clinical trials that led to FDA approvals in B-cell lymphoma. The current focus of the Lymphoma and Leukemia Research Team is to improve treatment response and cure via novel combinations of targeted therapeutic agents and to optimize anti-lymphoma immunotherapy.
Research Description
Dr. Williams was recognized in 2023 with the Master Clinician Award in the UVA School of Medicine. He is an Emeritus member of the Lymphoma Research Foundation’s Scientific Advisory Board and was the inaugural Chair of the Mantle Cell Consortium. He was awarded the inaugural LRF Mantle Cell Lymphoma Leadership Award in 2021 and honored by establishment of the Dr. Michael Williams Abstract Achievement Award for MCL Research.
He is a member of the U.S. Eastern Cooperative Oncology Group Lymphoma Core Committee, and of the European Mantle Cell Lymphoma Network. Dr. Williams is past Chair of the Hematology Subspecialty Board of the American Board of Internal Medicine, a past member of the ABIM Council, and currently serves on ABIM’s Hematology Longitudinal Knowledge Assessment Committee. He is the Associate Editor for Hematologic Malignancies for the NEJM Group Journal Watch Oncology and Hematology. He contributes regularly to national and international programs in research and education for lymphoma and CLL.